Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. - Wikidata - wikimedia - TriplyDB

Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.

Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.

http://www.wikidata.org/entity/Q35111780

about

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.Comparison of two instruments for measurement of quality of life in clinical practice--a qualitative study.Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial.Relationship between deficits in overall quality of life and non-small-cell lung cancer survival Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.Physicians' Use of Patients' Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer Trials.Quality of life during chemotherapy in lung cancer patients: results across different treatment lines Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.Social support and quality of life among lung cancer patients: a systematic review.First-line management of EGFR-mutated advanced lung adenocarcinoma: recent developments.Quality of reporting of chemotherapy compliance in randomized controlled trials of breast cancer treatment.Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.The prognostic value of pre-diagnosis health-related quality of life on survival: a prospective cohort study of older Americans with lung cancer.Depression symptom trends and health domains among lung cancer patients in the CanCORS study.Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of Life-Brief among lung cancer patients.MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3.Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.Health-related quality of life after first-line anti-cancer treatments for advanced non-small cell lung cancer in clinical practice.Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.Enabling, Not Cultivating: Received Social Support and Self-Efficacy Explain Quality of Life After Lung Cancer Surgery.Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer.Measurement of health-related quality of life during chemotherapy - the importance of timing.MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1.

P2860

Q28068435-A71E8E28-9F12-434F-8B37-F2CB5261A4DC Q28087212-94045505-9EC4-492C-9F82-EDA963D20453 Q30671538-5C33BA92-43C6-45F6-854E-F2AC9BA9B9F5 Q31034367-C23004AC-7E46-4751-9018-9C4834F04EF0 Q34041802-3B41A109-1E48-447F-992A-ADBBA7AE0803 Q34410272-6AB8FBB1-026D-457A-A28B-C99335BF4B3C Q35711157-37746132-3831-47FA-AE6D-A65A2ED70080 Q36058286-460D1038-F46B-418A-B5DC-B89E2227CDC9 Q36584771-A737F6FD-39C0-44A3-B055-25063A5DED64 Q37182205-370225F0-F26F-4F71-ABBB-834AED870FDB Q37184128-E7875A79-6B01-4F91-9849-58699A535F2B Q37279248-0ABF6F87-FAE5-4E35-B0A7-BD8986AC274C Q38053978-D298F4AD-BFF2-4F8D-A2B0-05737D47A447 Q38055463-25D7AFD2-2491-41F5-914A-7718DE0851D6 Q38088215-A71B64B2-DDC8-43B5-8D38-02FE974E32F7 Q38522820-EB8AA986-A25F-4B17-B4B9-4EA260210393 Q38602994-E2A5AF13-B5D6-4E4D-8F5E-6B89B5A1311E Q38757921-27C6242F-38E5-469D-AAC7-4B1C3286D6D3 Q38824129-ABC4BB98-D673-4ACD-B1BA-49DB8D62B69F Q40562500-5F82495E-62DB-498A-B462-7F8ECB02BDFE Q42318075-4135023E-BD05-4E97-B169-D3439FDFF7B1 Q44485496-7ED9BFF3-BBDE-4801-88D9-4C241F8C9457 Q45291178-11615101-2FA2-44BE-A349-AEFEA2B8A9D7 Q46255750-DC708191-C702-4B60-9BE1-7701EDF22CFB Q47698111-449A1E7D-7587-4F7D-8996-F53FCD3C7C00 Q48112495-A4E47177-D289-4748-9C6C-CCB77CC60806 Q48185503-ED3C6DFC-C403-44A7-A115-AA4F8556DAF8 Q50935978-3DE572EB-CF6E-401B-A2BD-59345904FE5F Q52726212-0C7E49A1-036F-48C0-B5CC-582D0296C341

P2860

Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.

http://www.wikidata.org/entity/Q35111780

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Health-related quality of life ...... randomized controlled trials.

@ast

Health-related quality of life ...... randomized controlled trials.

@en

Health-related quality of life ...... randomized controlled trials.

@en-gb

type

label

Health-related quality of life ...... randomized controlled trials.

@ast

Health-related quality of life ...... randomized controlled trials.

@en

Health-related quality of life ...... randomized controlled trials.

@en-gb

prefLabel

Health-related quality of life ...... randomized controlled trials.

@ast

Health-related quality of life ...... randomized controlled trials.

@en

Health-related quality of life ...... randomized controlled trials.

@en-gb

P1433

Q35111780-92702BEE-A8DA-4A22-AFD3-5A36F4C25B9B

P1476

Q35111780-61DCDBDA-74E0-4EDC-9DD5-0A3D9496280A

P2093

Q35111780-16392214-3B2A-4382-81F6-E22E33BA0179

Q35111780-34069D1B-7D3F-46F9-9B17-C1DC53905A4A

Q35111780-3ECE7851-C6AA-4042-8D6C-3B418ED3CCAE

Q35111780-9E950911-C833-4326-974C-3FB7966B8777

Q35111780-C64259A1-063F-4A1E-89BF-B4FC6D953427

Q35111780-DD6BE6A7-75A3-4B3F-9F0F-FA6073836869

Q35111780-F59799ED-9B1E-4098-AD46-A35F2B62DFDB

P2860

Q35111780-01E181BD-5B54-45E6-A613-7D819B507B5E

Q35111780-03DE64D0-70E8-49CF-BDC0-468F68ADB5DA

Q35111780-072A7CAF-9B4B-4F5C-9A17-282E4AA50A4C

Q35111780-088FCE66-E94E-4824-BA5D-DE3865876A2C

Q35111780-121744D7-621A-4BF4-8392-DD6AF6C7C0E8

Q35111780-189BFBCD-B11F-4EE7-ACAC-6AE6425B6B7D

Q35111780-1950227A-7AFF-4601-8644-6100D497430D

Q35111780-1A724E5F-5946-400B-84C2-BD1A50970FE3

Q35111780-1E28B464-8427-4B79-A30A-28A7371E190B

Q35111780-1FD0DD6F-E67A-4C4D-8130-74B476B81944

P304

Q35111780-738301EF-2039-4CDD-A0D5-8ABC7EBC04B9

P31

Q35111780-B7EBE428-D549-4772-9557-6EDE5C8BB696

P356

Q35111780-396E18CE-E21C-4DE2-B09B-DE3680E3B193

P407

Q35111780-E931422A-22CD-4745-BB1A-D701E1F4E6A1

P433

Q35111780-EB8DBD4E-D7F4-4EA3-995B-605916714FBA

P478

Q35111780-BC13D158-6BBE-4541-9383-16234A15F527

P50

Q35111780-090AC787-FACA-4708-B3FD-05834C53995E

Q35111780-58BEEA28-5534-41F4-994F-AB3D6111E51B

P577

Q35111780-2078FDB6-C620-4D65-B9EC-81C8F5D31426

P5875

Q35111780-6173EAD0-516E-4ACB-A985-0A946DBA4F39

P698

Q35111780-F31137C0-64DF-4CF6-A9A5-DFEA5942B587

P921

Q35111780-987877C5-4E3F-4442-8850-3793E9358DA5

P932

Q35111780-339CD18B-6787-4493-80C5-F728A04263A8

P356

JCO.2010.32.3683

P1433

Journal of Clinical Oncology

P1476

Health-related quality of life ...... randomized controlled trials.

@en

P2093

Chantal Quinten

http://www.w3.org/2001/XMLSchema#string

Corneel Coens

http://www.w3.org/2001/XMLSchema#string

Elizabeth K Sloan

http://www.w3.org/2001/XMLSchema#string

Irina Ghislain

http://www.w3.org/2001/XMLSchema#string

Jan van Meerbeeck

http://www.w3.org/2001/XMLSchema#string

Lily Claassens

http://www.w3.org/2001/XMLSchema#string

Xin Shelly Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study.

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

P304

2104-2120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.32.3683

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Galina Velikova

Andrew Bottomley

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50999681

http://www.w3.org/2001/XMLSchema#string

P698

21464420

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3138547

http://www.w3.org/2001/XMLSchema#string